Both carvedilol and nebivolol may improve platelet function and prothrombotic state in patients with nonischemic heart failure.
about
A Review of Nebivolol Pharmacology and Clinical EvidenceMean Platelet Volume as a Predictor of Heart Failure-Related Hospitalizations in Stable Heart Failure Outpatients with Sinus Rhythm.Left atrial function predicts heart failure events in patients with newly diagnosed left ventricular systolic heart failure during short-term follow-up.
P2860
Both carvedilol and nebivolol may improve platelet function and prothrombotic state in patients with nonischemic heart failure.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Both carvedilol and nebivolol ...... ith nonischemic heart failure.
@en
Both carvedilol and nebivolol ...... ith nonischemic heart failure.
@nl
type
label
Both carvedilol and nebivolol ...... ith nonischemic heart failure.
@en
Both carvedilol and nebivolol ...... ith nonischemic heart failure.
@nl
prefLabel
Both carvedilol and nebivolol ...... ith nonischemic heart failure.
@en
Both carvedilol and nebivolol ...... ith nonischemic heart failure.
@nl
P2093
P2860
P356
P1433
P1476
Both carvedilol and nebivolol ...... ith nonischemic heart failure.
@en
P2093
Abdullah Dogan
Dogan Erdogan
Fatih Aksoy
Mehmet Ozaydin
Mustafa Karabacak
Pinar Karabacak
P2860
P304
P356
10.1177/0003319713489340
P577
2013-05-13T00:00:00Z